HEALTHSEMAFOR
WHO plans Ebola vaccine trials
The WHO is conducting two trials of experimental anti-Ebola drugs, with the US supplying one drug after changing its policy. The outbreak in the Democratic Republic of Congo has over 1,000 cases, and the Bundibugyo strain's milder symptoms may hinder detection.
Mentioned
Related Signal
Adjacent reporting
- Exclusive: Race begins to trial Ebola drugs amid current outbreak
- Ebola vaccine for Bundibugyo strain could take months before human trials
- Bird flu vaccine trial against potential pandemic strain begins
- Ebola outbreak: When will a vaccine be developed for the new strain?
- Three Ebola vaccines in development amid growing outbreak fears